What is patent ductus arteriosus (PDA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Patent Ductus Arteriosus (PDA) Definition

Patent ductus arteriosus (PDA) is a congenital cardiovascular finding in which the ductus arteriosus, a vascular connection between the aorta and pulmonary artery that is normally present during fetal life, remains open beyond the normal age of spontaneous closure after birth. 1

Anatomical Features

  • The ductus arteriosus connects the proximal left pulmonary artery to the descending aorta just distal to the left subclavian artery 1
  • In fetal circulation, this connection is essential for normal development
  • Normally closes within 24-48 hours after birth in full-term infants 2
  • Failure to close results in persistent communication between systemic and pulmonary circulation

Epidemiology

  • Incidence: 0.3% to 0.8% of term infants 1
  • More common in preterm infants, especially those with low birth weight 2, 3
  • Female to male ratio is 2:1 2

Pathophysiology

The hemodynamic consequences of PDA depend on:

  1. Size of the ductus:

    • Small: hemodynamically insignificant, often asymptomatic 1
    • Moderate to large: hemodynamically significant, can cause clinical symptoms 1
  2. Direction of blood flow:

    • Left-to-right shunt: Most common, causes pulmonary overcirculation
    • Right-to-left shunt: Occurs with pulmonary hypertension, causes cyanosis
  3. Pulmonary vascular resistance relative to systemic resistance:

    • Determines the magnitude and direction of shunting 1

Clinical Presentations

PDA can present with various clinical manifestations:

  • Small PDA: Often asymptomatic with normal left ventricle and pulmonary artery pressure 1
  • Moderate PDA with left ventricular volume overload: Enlarged left ventricle with normal or reduced function, may present with left heart failure 1
  • Moderate PDA with pulmonary arterial hypertension: Pressure-overloaded right ventricle, may present with right heart failure 1
  • Large PDA with Eisenmenger physiology: Differential hypoxemia and cyanosis (lower extremities and sometimes left arm show cyanosis) 1

Diagnostic Features

  • Physical examination: Continuous "machinery" murmur (loudest in the left upper chest or infraclavicular area) 2
  • Peripheral signs: Bounding pulses with wide pulse pressure in left-to-right shunts 1, 2
  • Oxygen saturation: Should be measured in both hands and feet to detect differential cyanosis 1

Classification of Severity

  • Small PDA: Likely to be hemodynamically insignificant 1
  • Moderate to large PDA: Likely to be hemodynamically significant 1

Associated Conditions

PDA may be associated with:

  • Chromosomal abnormalities (trisomy 21, trisomy 18) 2
  • Genetic syndromes (Rubinstein-Taybi, CHARGE syndrome) 2
  • Birth at high altitude 2
  • Congenital rubella 2

Clinical Implications

Untreated moderate to large PDAs can lead to:

  • Congestive heart failure 1, 2
  • Pulmonary hypertension 1, 2
  • Failure to thrive 2
  • Recurrent respiratory infections 2
  • Risk of endarteritis (though relatively low) 1

Management Considerations

Management depends on size, hemodynamic significance, and patient age:

  • Closure is recommended when there is left atrial or left ventricular enlargement attributable to PDA with net left-to-right shunt and pulmonary artery systolic pressure less than 50% systemic 1
  • Closure may be considered with net left-to-right shunt if pulmonary artery systolic pressure is ≥50% systemic 1
  • Closure should not be performed in adults with net right-to-left shunt and pulmonary artery systolic pressure greater than two-thirds systemic 1

Closure Methods

  • Transcatheter closure: Preferred method in adults when technically suitable 1
  • Surgical closure: Alternative when percutaneous approach is not feasible 1

Understanding PDA is essential for appropriate management decisions to prevent complications and improve long-term outcomes in affected individuals.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Patent arterial duct.

Orphanet journal of rare diseases, 2009

Research

Understanding the Pathophysiology, Implications, and Treatment Options of Patent Ductus Arteriosus in the Neonatal Population.

Advances in neonatal care : official journal of the National Association of Neonatal Nurses, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.